SK Biopharm Holds On-Site Sales Meeting in the U.S.

Over 290 Executives and Employees from Korea and Abroad Attend

SK Biopharm announced on the 12th that its U.S. subsidiary, SK Life Science, held the "2026 National Sales Meeting" in Orlando, Florida, from the 9th to the 12th.

On-site photos from SK Biopharm's U.S. sales meeting. SK Biopharm

This event has been held every year since the epilepsy treatment Cenobamate was launched in the United States in 2020. This year marks the seventh meeting. More than 290 executives and employees from Korea and overseas, including President Lee Donghoon, attended. All members of the U.S. subsidiary took part to share last year’s achievements and review this year’s sales strategy.

This year’s slogan is "We Will." It emphasized members’ execution capabilities and proactive growth.

The core of the event is the "One Team" strategy, under which the headquarters and the U.S. subsidiary cooperate with the same direction and priorities. The company plans to pool expertise across each division, including research and development and strategic marketing, to strengthen the Cenobamate business and lay the foundation for expansion into the oncology field.

On site, lectures were given from the perspectives of patients and healthcare professionals. Through workshops led by the sales staff, the company reviewed its marketing strategies and execution capabilities.

Cenobamate recorded sales of 630.3 billion won in the U.S. market in 2025, up about 44% from the previous year. The company described this as its best performance ever.

The company plans to accelerate its push to turn Cenobamate into a global blockbuster through physician-tailored marketing and a strategy to increase prescription share.

President Lee said, "The essence of the 'One Team' strategy is to break down organizational boundaries and move in the same direction, based on shared goals and priorities," adding, "We will use the success of Cenobamate as a springboard to expand our business and establish a virtuous cycle in which all members proactively shape the future."

This content was produced with the assistance of AI translation services.